Support By : Li-lab
| PATHWAY_NAME | REACTOME_ID | KEGG_ID | DRUG_NAME | PUBCHEM_CID | Datasource |
|---|---|---|---|---|---|
| Allograft rejection | R-HSA-9679028 | map05330 | sulindac | 1548887 | drug-path |
| Type I diabetes mellitus | R-HSA-5683209 | map04940 | sulindac | 1548887 | drug-path |
| Neuroactive ligand-receptor interaction | R-HSA-5632681 | map04080 | sulindac | 1548887 | drug-path |
| Huntington's disease | R-HSA-1643685 | 0 | sulindac | 1548887 | drug-path |
| Cell adhesion molecules (CAMs) | R-HSA-1031690 | 0 | sulindac | 1548887 | drug-path |
| Cytokine-cytokine receptor interaction | R-HSA-6788467 | map04060 | sulindac | 1548887 | drug-path |
| Vascular smooth muscle contraction | R-HSA-445355 | map04270 | sulindac | 1548887 | drug-path |
| Chronic myeloid leukemia | R-HSA-9680350 | map05220 | sulindac | 1548887 | drug-path |
| Ubiquitin mediated proteolysis | R-HSA-983153 | map04120 | amitriptyline | 2160 | drug-path |
| Insulin signaling pathway | R-HSA-74752 | map04910 | amitriptyline | 2160 | drug-path |
| Olfactory transduction | R-HSA-9751605 | map04740 | amitriptyline | 2160 | drug-path |
| Systemic lupus erythematosus | R-HSA-977105 | map05322 | amitriptyline | 2160 | drug-path |
| Ribosome | R-HSA-5368277 | map03010 | amitriptyline | 2160 | drug-path |
| Neuroactive ligand-receptor interaction | R-HSA-5632681 | map04080 | amitriptyline | 2160 | drug-path |
| Cytokine-cytokine receptor interaction | R-HSA-6788467 | map04060 | amitriptyline | 2160 | drug-path |
| Neuroactive ligand-receptor interaction | R-HSA-5632681 | map04080 | 15-delta prostaglandin J2 | None | drug-path |
| Huntington's disease | R-HSA-1643685 | 0 | 15-delta prostaglandin J2 | None | drug-path |
| Olfactory transduction | R-HSA-9751605 | map04740 | 15-delta prostaglandin J2 | None | drug-path |
| Systemic lupus erythematosus | R-HSA-977105 | map05322 | 15-delta prostaglandin J2 | None | drug-path |
| Regulation of actin cytoskeleton | R-HSA-392751 | map04810 | 15-delta prostaglandin J2 | None | drug-path |